MDR1 and MDR3 genes and drug resistance to cisplatin of ovarian cancer cells

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 27, Issue 6, 2007, Pages 721-724

  Ren, Lirong ^a   Xiao, Lan ^a   Hu, Jianli ^a   Li, Zhimin ^a   Wang, Zehua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

A2780 DDP cells; Apoptosis; Cisplatin; P glycoprotein; RNA interference

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 3; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; DRUG RESISTANCE; FEMALE; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; OVARIAN NEOPLASMS; P-GLYCOPROTEIN; P-GLYCOPROTEINS; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 38849141103     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-007-0627-7     Document Type: Article

References (10)

1. Krasznai Z T, Friedlander E, Nagy A et al. Quantitative and functional assay of MDR1/P170-mediated MDR in ascites cells of patients with ovarian cancer. Anticancer Res, 2005,25,1187-1192
2. Yoshimura N, Kudoh S, Mukohara T et al. Phase I/II study of cisplatin combined with weekly paclitaxel in patients with advanced non-small-cell lung cancer. Br J Cancer, 2004,90: 1184-1189
3. Hilary T, Coley H M. Overcoming multidrug resistance in Cancer: An Update on the Clinical Strategy of inhibiting P-Glycoprotein. Cancer Control, 2003,10(2):159-165
4. Bergman A M, Pinedo H M, Talianidis I. Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines. Br J Cancer, 2003,88(12):1963-1970
5. Inoue Y, Gika M, Abiko T et al. Bcl-2 overexpression enhances in vitro sensitivity against docetaxel in non-small cell lung cancer. Oncol Rep, 2005,13(2):259-264
6. Smith A J, van Helvoort A, van Meer G et al. MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping. J Biol Chem, 2000,275:23530-23539
7. Fesik S W. Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer, 2005,5(11):876-885
8. Mantovani I, Cappellini A, Tazzari P L et al. Caspase-dependent cleavage of 170-kDa P-glycoprotein during apoptosis of human T-lymphoblastoid CEM cells. J Cell Physiol, 2006,207(3):836-844
9. Cheng T C, Manorek G, Samimi G et al. Identification of genes whose expression is associated with cisplatin resistance in human ovarian carcinoma cells. Cancer Chemother Pharmacol, 2006,58(3):384-395
10. Mozzetti S, Ferlini C, Concolino P et al. Class III β-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients. Clin Cancer Res, 2005, 11(1):298-305